Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.46
CPTS's Cash to Debt is ranked lower than
99.99% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. CPTS: 1.46 )
Ranked among companies with meaningful Cash to Debt only.
CPTS' s Cash to Debt Range Over the Past 10 Years
Min: 0.47  Med: 88.71 Max: No Debt
Current: 1.46
Equity to Asset 0.57
CPTS's Equity to Asset is ranked lower than
99.99% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. CPTS: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
CPTS' s Equity to Asset Range Over the Past 10 Years
Min: 0.05  Med: 0.73 Max: 0.92
Current: 0.57
0.05
0.92
Interest Coverage 3.00
CPTS's Interest Coverage is ranked lower than
99.99% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.76 vs. CPTS: 3.00 )
Ranked among companies with meaningful Interest Coverage only.
CPTS' s Interest Coverage Range Over the Past 10 Years
Min: 1  Med: 10000.00 Max: 1000
Current: 3
1
1000
F-Score: 7
Z-Score: 8.04
M-Score: -2.42
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 9.50
CPTS's Operating margin (%) is ranked lower than
99.99% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. CPTS: 9.50 )
Ranked among companies with meaningful Operating margin (%) only.
CPTS' s Operating margin (%) Range Over the Past 10 Years
Min: -1575000  Med: -77.35 Max: 11.1
Current: 9.5
-1575000
11.1
Net-margin (%) 3.80
CPTS's Net-margin (%) is ranked lower than
99.99% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. CPTS: 3.80 )
Ranked among companies with meaningful Net-margin (%) only.
CPTS' s Net-margin (%) Range Over the Past 10 Years
Min: -1445300  Med: -73.55 Max: 58.3
Current: 3.8
-1445300
58.3
ROE (%) 3.10
CPTS's ROE (%) is ranked lower than
99.99% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. CPTS: 3.10 )
Ranked among companies with meaningful ROE (%) only.
CPTS' s ROE (%) Range Over the Past 10 Years
Min: -145.1  Med: -53.65 Max: 54.1
Current: 3.1
-145.1
54.1
ROA (%) 2.20
CPTS's ROA (%) is ranked lower than
99.99% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. CPTS: 2.20 )
Ranked among companies with meaningful ROA (%) only.
CPTS' s ROA (%) Range Over the Past 10 Years
Min: -102.5  Med: -44.05 Max: 32.7
Current: 2.2
-102.5
32.7
ROC (Joel Greenblatt) (%) 38.40
CPTS's ROC (Joel Greenblatt) (%) is ranked lower than
99.99% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.53 vs. CPTS: 38.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CPTS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -40912.3  Med: -133.40 Max: 72.2
Current: 38.4
-40912.3
72.2
Revenue Growth (3Y)(%) 0.60
CPTS's Revenue Growth (3Y)(%) is ranked lower than
99.99% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.10 vs. CPTS: 0.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CPTS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 41.70 Max: 99
Current: 0.6
0
99
EBITDA Growth (3Y)(%) 1.20
CPTS's EBITDA Growth (3Y)(%) is ranked lower than
99.99% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. CPTS: 1.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CPTS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -22.8  Med: -2.70 Max: 22.1
Current: 1.2
-22.8
22.1
EPS Growth (3Y)(%) -10.60
CPTS's EPS Growth (3Y)(%) is ranked lower than
99.99% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. CPTS: -10.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CPTS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -16.80 Max: 22.5
Current: -10.6
0
22.5
» CPTS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with CPTS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details


Conceptus Inc., was incorporated in the state of Delaware on September 18, 1992. It designs, develops, markets and promotes innovative solutions in women's healthcare. The Company's flagship product is the proprietary Essure permanent birth control procedure, which is the most effective non-surgical permanent birth control available, based on a comparison of four-year clinical trial data. The Essure procedure delivers a soft and flexible insert into a woman's fallopian tubes, causing a benign tissue in-growth which blocks the fallopian tubes. Successfully placed Essure inserts and the subsequent tissue growth around and through the inserts prohibits the egg from traveling through the fallopian tube, preventing conception. It sells the Essure procedure directly in France through its wholly owned subsidiary, Conceptus SAS (SAS), and in the United Kingdom through its wholly owned subsidiary Conceptus Medical Limited (CML). In October 2011, it purchased certain assets of Sigma Medical and established a wholly owned subsidiary in the Netherlands, Conceptus B.V. (BV). In the rest of the world, it sells indirectly through a network of distributors. The manufacture and sale of its product are subject to extensive regulation by numerous governmental authorities, principally the FDA as well as state agencies.

Ratios

vs
industry
vs
history
P/E(ttm) 110.70
CPTS's P/E(ttm) is ranked lower than
99.99% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.16 vs. CPTS: 110.70 )
Ranked among companies with meaningful P/E(ttm) only.
CPTS' s P/E(ttm) Range Over the Past 10 Years
Min: 4.25  Med: 81.33 Max: 1582
Current: 110.7
4.25
1582
PE(NRI) 110.70
CPTS's PE(NRI) is ranked lower than
99.99% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.68 vs. CPTS: 110.70 )
Ranked among companies with meaningful PE(NRI) only.
CPTS' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0
Current: 110.7
P/B 5.80
CPTS's P/B is ranked lower than
99.99% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. CPTS: 5.80 )
Ranked among companies with meaningful P/B only.
CPTS' s P/B Range Over the Past 10 Years
Min: 2.05  Med: 8.64 Max: 36.17
Current: 5.8
2.05
36.17
P/S 7.14
CPTS's P/S is ranked lower than
99.99% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. CPTS: 7.14 )
Ranked among companies with meaningful P/S only.
CPTS' s P/S Range Over the Past 10 Years
Min: 2.45  Med: 13.32 Max: 1752
Current: 7.14
2.45
1752
PFCF 48.40
CPTS's PFCF is ranked lower than
99.99% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.49 vs. CPTS: 48.40 )
Ranked among companies with meaningful PFCF only.
CPTS' s PFCF Range Over the Past 10 Years
Min: 17.54  Med: 48.52 Max: 2220
Current: 48.4
17.54
2220
EV-to-EBIT 47.60
CPTS's EV-to-EBIT is ranked lower than
99.99% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.36 vs. CPTS: 47.60 )
Ranked among companies with meaningful EV-to-EBIT only.
CPTS' s EV-to-EBIT Range Over the Past 10 Years
Min: 24.5  Med: 53.00 Max: 634.6
Current: 47.6
24.5
634.6
EV-to-EBITDA 33.94
CPTS's EV-to-EBITDA is ranked lower than
99.99% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.91 vs. CPTS: 33.94 )
Ranked among companies with meaningful EV-to-EBITDA only.
CPTS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0
Current: 33.94
PEG 7.00
CPTS's PEG is ranked lower than
99.99% of the 60 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.58 vs. CPTS: 7.00 )
Ranked among companies with meaningful PEG only.
CPTS' s PEG Range Over the Past 10 Years
Min: 0  Med: 1.23 Max: 24.83
Current: 7
0
24.83
Shiller P/E 70.70
CPTS's Shiller P/E is ranked lower than
99.99% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 37.39 vs. CPTS: 70.70 )
Ranked among companies with meaningful Shiller P/E only.
CPTS' s Shiller P/E Range Over the Past 10 Years
Min: 45.36  Med: 58.32 Max: 135.82
Current: 70.7
45.36
135.82
Current Ratio 5.78
CPTS's Current Ratio is ranked lower than
99.99% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. CPTS: 5.78 )
Ranked among companies with meaningful Current Ratio only.
CPTS' s Current Ratio Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0
Current: 5.78
Quick Ratio 2.14
CPTS's Quick Ratio is ranked lower than
99.99% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. CPTS: 2.14 )
Ranked among companies with meaningful Quick Ratio only.
CPTS' s Quick Ratio Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0
Current: 2.14

Valuation & Return

vs
industry
vs
history
Price/Net Cash 1034.00
CPTS's Price/Net Cash is ranked lower than
99.99% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.21 vs. CPTS: 1034.00 )
Ranked among companies with meaningful Price/Net Cash only.
CPTS' s Price/Net Cash Range Over the Past 10 Years
Min: 3.5  Med: 12.20 Max: 700
Current: 1034
3.5
700
Price/Net Current Asset Value 50.90
CPTS's Price/Net Current Asset Value is ranked lower than
99.99% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.97 vs. CPTS: 50.90 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
CPTS' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 26.3  Med: 54.10 Max: 164.1
Current: 50.9
26.3
164.1
Price/Tangible Book 7.30
CPTS's Price/Tangible Book is ranked lower than
99.99% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.63 vs. CPTS: 7.30 )
Ranked among companies with meaningful Price/Tangible Book only.
CPTS' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.2  Med: 8.70 Max: 56.4
Current: 7.3
3.2
56.4
Price/Projected FCF 5.10
CPTS's Price/Projected FCF is ranked lower than
99.99% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. CPTS: 5.10 )
Ranked among companies with meaningful Price/Projected FCF only.
CPTS' s Price/Projected FCF Range Over the Past 10 Years
Min: 2.7  Med: 3.80 Max: 11.1
Current: 5.1
2.7
11.1
Price/Median PS Value 0.50
CPTS's Price/Median PS Value is ranked lower than
99.99% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. CPTS: 0.50 )
Ranked among companies with meaningful Price/Median PS Value only.
CPTS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.2  Med: 0.90 Max: 59
Current: 0.5
0.2
59
Price/Graham Number 7.90
CPTS's Price/Graham Number is ranked lower than
99.99% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. CPTS: 7.90 )
Ranked among companies with meaningful Price/Graham Number only.
CPTS' s Price/Graham Number Range Over the Past 10 Years
Min: 1  Med: 5.30 Max: 11
Current: 7.9
1
11
Earnings Yield (Greenblatt) (%) 2.10
CPTS's Earnings Yield (Greenblatt) (%) is ranked lower than
99.99% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. CPTS: 2.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CPTS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.2  Med: 1.90 Max: 4.1
Current: 2.1
0.2
4.1
Forward Rate of Return (Yacktman) (%) 0.30
CPTS's Forward Rate of Return (Yacktman) (%) is ranked lower than
99.99% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.42 vs. CPTS: 0.30 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CPTS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -7.6  Med: -2.00 Max: 0.6
Current: 0.3
-7.6
0.6

More Statistics

Short Percentage of Float0.00%
52-Week Range $16.88 - 31.10
Shares Outstanding (Mil)32.54

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)